Cargando…
Pathological Role of Interleukin-6 in Psoriatic Arthritis
Psoriatic arthritis (PsA) is a clinical manifestation of psoriatic disease. Although the pathogenesis of PsA remains unknown, PsA can be managed by treatments similar to those used for rheumatoid arthritis (RA). Because interleukin-(IL-) 6 has been suggested to have a pathogenic role in PsA, a human...
Autores principales: | Ogata, Atsushi, Kumanogoh, Atsushi, Tanaka, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485872/ https://www.ncbi.nlm.nih.gov/pubmed/23133751 http://dx.doi.org/10.1155/2012/713618 |
Ejemplares similares
-
Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014) -
DNA Damage in Rheumatoid Arthritis: An Age-Dependent Increase in the Lipid Peroxidation-Derived DNA Adduct, Heptanone-Etheno-2′-Deoxycytidine
por: Ogawa, Masako, et al.
Publicado: (2013) -
Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions
por: Ogata, Atsushi, et al.
Publicado: (2012) -
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
por: Tanaka, Toshio, et al.
Publicado: (2014) -
The pathological role of Wnt5a in psoriasis and psoriatic arthritis
por: Tian, Faming, et al.
Publicado: (2019)